Advances in targeting co‐inhibitory and co‐stimulatory pathways in transplantation settings: the Yin to the Yang of cancer immunotherapy

LS Kean, LA Turka, BR Blazar - Immunological reviews, 2017 - Wiley Online Library
In the past decade, the power of harnessing T‐cell co‐signaling pathways has become
increasingly understood to have significant clinical importance. In cancer immunotherapy …
被引用次数：49 相关文章

Advances in targeting co‐inhibitory and co‐stimulatory pathways in transplantation settings: the Yin to the Yang of cancer immunotherapy

LS Kean, LA Turka, BR Blazar - Immunological Reviews, 2017 - infona.pl
In the past decade, the power of harnessing T‐cell co‐signaling pathways has become
increasingly understood to have significant clinical importance. In cancer immunotherapy …

Advances in targeting co-inhibitory and co-stimulatory pathways in transplantation settings: the Yin to the Yang of cancer immunotherapy

LS Kean, LA Turka, BR Blazar - Immunological reviews, 2017 - pubmed.ncbi.nlm.nih.gov
In the past decade, the power of harnessing T-cell co-signaling pathways has become
increasingly understood to have significant clinical importance. In cancer immunotherapy …
[HTML] nih.gov

[HTML][HTML] Advances in Targeting Co-inhibitory and Co-stimulatory Pathways in Transplantation Settings: The Yin to the Yang of Cancer Immunotherapy

LS Kean, LA Turka, BR Blazar - Immunological reviews, 2017 - ncbi.nlm.nih.gov
In the past decade, the power of harnessing T cell co-signaling pathways has become
increasingly understood to have significant clinical importance. In cancer immunotherapy …

Advances in targeting co-inhibitory and co-stimulatory pathways in transplantation settings: the Yin to the Yang of cancer immunotherapy.

LS Kean, LA Turka, BR Blazar - Immunological Reviews, 2017 - search.ebscohost.com
In the past decade, the power of harnessing T-cell co-signaling pathways has become
increasingly understood to have significant clinical importance. In cancer immunotherapy …

[引用][C] Advances in targeting co-inhibitory and co-stimulatory pathways in transplantation settings: the Yin to the Yang of cancer immunotherapy

LS Kean, LA Turka, BR Blazar - Immunological Reviews, 2017 - cir.nii.ac.jp
Advances in targeting co-inhibitory and co-stimulatory pathways in transplantation settings: the
Yin to the Yang of cancer immunotherapy | CiNii Research CiNii 国立情報学研究所 学術情報 …
[HTML] europepmc.org

[HTML][HTML] Advances in targeting co-inhibitory and co-stimulatory pathways in transplantation settings: the Yin to the Yang of cancer immunotherapy.

LS Kean, LA Turka, BR Blazar - Immunological Reviews, 2017 - europepmc.org
In the past decade, the power of harnessing T cell co-signaling pathways has become
increasingly understood to have significant clinical importance. In cancer immunotherapy …

Advances in targeting co-inhibitory and co-stimulatory pathways in transplantation settings: the Yin to the Yang of cancer immunotherapy

LS Kean, LA Turka, BR Blazar - Immunological Reviews, 2017 - experts.umn.edu
In the past decade, the power of harnessing T-cell co-signaling pathways has become
increasingly understood to have significant clinical importance. In cancer immunotherapy …
[PDF] immunetolerance.org

[PDF][PDF] Advances in targeting co-inhibitory and co-stimulatory pathways in transplantation settings: the Yin to the Yang of cancer immunotherapy

LS Kean, LA Turka, BR Blazar - Immunological Reviews, 2017 - immunetolerance.org
In the past decade, the power of harnessing T-cell co-signaling pathways has become
increasingly understood to have significant clinical importance. In cancer immunotherapy …

Advances in targeting co-inhibitory and co-stimulatory pathways in transplantation settings: the Yin to the Yang of cancer immunotherapy.

LS Kean, LA Turka, BR Blazar - Immunological Reviews, 2017 - europepmc.org
In the past decade, the power of harnessing T cell co-signaling pathways has become
increasingly understood to have significant clinical importance. In cancer immunotherapy …